59.98
0.00 (0.00%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 混合的 |
| Biotechnology (全球的) | 混合的 | 混合的 | |
| 股票 | Longboard Pharmaceuticals, Inc. | 混合的 | 看涨 |
AIStockmoo 评分
| 分析师共识 | 0.5 |
| 内部交易活动 | NA |
| 价格波动 | -0.5 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | 1.0 |
| 平均 | 0.25 |
|
Longboard Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases. The company is working to improve a portfolio of centrally acting product candidates designed to be selective for specific G protein-coupled receptors (GPCRs). The company is evaluating LP352, an oral, centrally acting 5-hydroxytryptamine 2C (5-HT2C) receptor superagonist, with negligible observed impact on 5-HT2B and 5-HT2A receptor subtypes, in development for the potential treatment of seizures associated with a broad range of developmental and epileptic encephalopathies. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Growth |
| 内部持股比例 | 1.20% |
| 机构持股比例 | 121.42% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 60.00 (Truist Securities, 0.03%) | 保留 |
| 60.00 (HC Wainwright & Co., 0.03%) | 保留 | |
| 60.00 (B. Riley Securities, 0.03%) | 保留 | |
| 中 | 60.00 (0.03%) | |
| 平均值 | 60.00 (0.03%) | |
| 总计 | 3 保留 | |
| 平均价格@调整类型 | 59.05 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| HC Wainwright & Co. | 15 Oct 2024 | 60.00 (0.03%) | 保留 | 59.08 |
| Truist Securities | 15 Oct 2024 | 60.00 (0.03%) | 保留 | 59.08 |
| B. Riley Securities | 14 Oct 2024 | 60.00 (0.03%) | 保留 | 58.99 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合